8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2012 / Randomized clinical study
A randomized clinical study compared a cow's milk-free diet (CMFD) to a cow's milk diet (CMD) in 140 children aged 1 to 13 years with chronic functional constipation unresponsive to laxatives for at least 3 months. After 4 weeks, 56 (80%) patients in the CMFD group responded compared to 33 (47.1%) in the CMD group (P=0.0001). Following a 2-week CMD challenge in the CMFD group, 24 of 56 (42.8%) responders developed constipation according to Rome III criteria. Only one of the 140 patients had a positive skin prick test.
Dehghani SM, Ahmadpour B, Haghighat M, et al. Iran J Pediatr, 2012. PMID 23429756
2012 / Randomized double-blind placebo-controlled clinical trial
A randomized double-blind placebo-controlled trial evaluated the effect of ginger on chemotherapy-induced vomiting in 80 women with breast cancer. Participants received either 250 mg ginger powder capsules or starch placebo capsules 4 times daily (1 g/day) for 6 days starting 3 days before chemotherapy. Vomiting cases were significantly lower in the ginger group at the anticipatory (P = 0.04), acute (P = 0.04), and delayed (P = 0.003) phases. Heartburn was the only side effect reported, and it was non-significant (P > 0.05).
Yekta ZP, Ebrahimi SM, Hosseini M, et al. Iran J Nurs Midwifery Res, 2012. PMID 23853643
2011 / Sequential dietary intervention trial
Fourteen overweight men consumed successively a control diet, diets high in resistant starch (RS) or non-starch polysaccharides (NSPs), and a reduced carbohydrate weight loss (WL) diet over 10 weeks. Relatives of Ruminococcus bromii increased in most volunteers on the RS diet to a mean of 17% of total bacteria compared to 3.8% on the NSP diet, while Eubacterium rectale relatives increased on RS (to mean 10.1%) but decreased alongside Collinsella aerofaciens on WL. Inter-individual variation was marked: >60% of RS was unfermented in two participants who had <1% R-ruminococci, compared to <4% unfermented in the other 12 volunteers.
Walker AW, Ince J, Duncan SH, et al. ISME J, 2011. PMID 20686513
2011 / Randomized controlled trial
A randomized, double-blind, placebo-controlled trial tested a daily probiotic formulation of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 for 30 days in healthy volunteers. Supplementation significantly lowered psychological distress on the HSCL-90 global severity index (p < 0.05), depression (p < 0.05), and anger-hostility (p < 0.05). Probiotic intake also reduced 24-hour urinary free cortisol levels (p < 0.05).
Messaoudi M, Lalonde R, Violle N, et al. Br J Nutr, 2011. PMID 20974015
2011 / Randomized double-blind crossover trial
Eleven patients with functional dyspepsia ingested 1.2 g ginger or placebo capsules after an 8-hour fast, followed 1 hour later by 500 mL of low-nutrient soup. Gastric emptying was significantly more rapid after ginger than placebo, with a median half-emptying time of 12.3 (8.5-17.0) minutes versus 16.1 (8.3-22.6) minutes (P<=0.05). A trend toward more antral contractions was observed (P=0.06), but fundus dimensions, gastrointestinal symptoms, and plasma levels of GLP-1, motilin, and ghrelin did not differ between treatments.
Hu ML, Rayner CK, Wu KL, et al. World J Gastroenterol, 2011. PMID 21218090
2011 / Randomized controlled trial
In a randomized trial with 34 patients, 13 of 19 participants (68%) receiving gluten reported uncontrolled symptoms compared to 6 of 15 (40%) on placebo (P=0.0001). Gluten significantly worsened pain, bloating, stool consistency satisfaction, overall symptoms, and tiredness within one week. However, gluten intake did not induce anti-gliadin antibodies or cause significant changes in inflammatory markers, celiac antibodies, or intestinal permeability.
Biesiekierski JR, Newnham ED, Irving PM, et al. Am J Gastroenterol, 2011. PMID 21224837
2011 / Randomized controlled trial
Twenty-four asymptomatic volunteers were randomized to receive intraduodenal infusion of fat, carbohydrate, or protein while lower esophageal sphincter (LES) function and reflux events were monitored. A significant linear decrease in LES pressure occurred during fat infusion (P=0.004), alongside a significant linear increase in CCK levels (P=0.02), whereas carbohydrate and protein infusions showed no such effects. CCK levels were inversely correlated with LES pressure (ρ = -0.43; P=0.04). Median esophageal acid exposure was significantly higher during fat infusion (1.10%; IQR: 0.25-4.7%) compared with carbohydrate (0.03%; IQR: 0.00-0.39%) and protein (0.03%; IQR: 0.00-0.39%) infusions (P=0.04).
Lacy BE, Carter J, Weiss JE, et al. Neurogastroenterol Motil, 2011. PMID 21435103
2011 / Randomized crossover trial
Fourteen women consumed fiber-matched and macronutrient-matched solid and liquid breakfasts in a randomized crossover study. Gastric emptying time was approximately one hour longer after the oatmeal and fruit meal than after the liquid meal. Subjects reported less hunger after the solid meal, along with marginal improvements in satisfaction and fullness, though lunchtime intake did not differ between conditions.
Willis HJ, Thomas W, Willis DJ, et al. Appetite, 2011. PMID 21435365
2011 / Randomized controlled trial
A multicenter trial randomized 206 young individuals with familial adenomatous polyposis to aspirin (600 mg/day), resistant starch (30 g/day), both, or placebos for 1 to 12 years. Among 133 patients with follow-up endoscopy, neither aspirin (RR = 0.77; 95% CI, 0.54-1.10) nor resistant starch (RR = 1.05; 95% CI, 0.73-1.49) significantly reduced rectal and sigmoid polyp numbers. Aspirin displayed a non-significant trend toward smaller maximum polyp size.
Burn J, Bishop DT, Chapman PD, et al. Cancer Prev Res (Phila), 2011. PMID 21543343
2011 / Inpatient dietary intervention study
In an inpatient study, 12 lean and 9 obese individuals consumed diets varying in caloric content (2400 compared with 3400 kcal/d) while gut microbiota and stool calories were measured. Altering nutrient load induced rapid shifts in gut microbiota. In lean individuals, these changes correlated with stool energy loss: a 20% increase in Firmicutes and corresponding decrease in Bacteroidetes was associated with an increased energy harvest of ≈150 kcal. A high degree of overfeeding in lean individuals was accompanied by a greater fractional decrease in stool energy loss.
Jumpertz R, Le DS, Turnbaugh PJ, et al. Am J Clin Nutr, 2011. PMID 21543530
2011 / Randomized controlled trial
Fifty patients with irritable bowel syndrome were randomized in a double-blind trial to receive either placebo (n=27) or 4 pills/day of enteric-coated red pepper powder (150 mg each; n=23) for 6 weeks. Eight patients dropped out (6 in the red pepper group due to abdominal pain, 2 in placebo), and 8 patients had their dosage reduced to 2 pills/day due to initial abdominal pain. In patients taking red pepper, mean abdominal pain and bloating scores during the final weeks improved significantly compared to pre-treatment values (unlike placebo), and patients rated treatment effectiveness significantly better than placebo.
Bortolotti M, Porta S Dig Dis Sci, 2011. PMID 21573941
2011 / Clinical trial with cross-sectional and crossover components
Researchers evaluated chewing characteristics and the effects of chew counts (15 vs. 40 chews per 10 g bite) on energy intake and postprandial gut hormones in 16 lean and 14 obese young men. Obese participants had a higher ingestion rate and fewer chews per gram of food compared to lean participants, with similar bite sizes. Regardless of weight status, participants ingested 11.9% less energy after 40 chews than after 15 chews. In both groups, 40 chews per bite also led to lower postprandial ghrelin levels and higher postprandial GLP-1 and cholecystokinin levels compared to 15 chews.
Li J, Zhang N, Hu L, et al. Am J Clin Nutr, 2011. PMID 21775556
2011 / Clinical trial
In a clinical trial, healthy men completed 60 minutes of cycling at 70% of maximum workload capacity. Exercise induced splanchnic hypoperfusion and significantly increased plasma markers of enterocyte damage (I-FABP and I-BABP, both P < 0.001) as well as small intestinal permeability (P < 0.001). Splanchnic hypoperfusion correlated with small intestinal damage (r = 0.59, P < 0.001), which also correlated with increased permeability (r = 0.50, P < 0.001).
van Wijck K, Lenaerts K, van Loon LJ, et al. PLoS One, 2011. PMID 21811592
2011 / Randomized controlled trial protocol
This protocol describes a randomized multicenter trial designed to assess green tea extract against placebo for preventing metachronous colon adenomas. A planned cohort of 2,534 post-polypectomy patients will receive 150 mg epigallocatechin gallate twice daily or placebo for 3 years. The primary endpoints include the incidence, count, and histology of adenomas identified during follow-up colonoscopy.
Stingl JC, Ettrich T, Muche R, et al. BMC Cancer, 2011. PMID 21851602
2011 / Cross-sectional study and controlled feeding trial
Researchers analyzed fecal samples from 98 individuals and observed communities clustering into Bacteroides and Prevotella enterotypes. Bacteroides was associated with protein and animal fat intake, whereas Prevotella was associated with carbohydrates. In a 10-person controlled feeding trial, high-fat or low-fat diets altered microbiome composition within 24 hours, though enterotypes remained stable across the 10-day period.
Wu GD, Chen J, Hoffmann C, et al. Science, 2011. PMID 21885731
2011 / Interventional trial with sequential treatment and dietary elimination
Eighty-one children with signs and symptoms of gastroesophageal reflux disease (GERD) received omeprazole for 4 weeks. Following omeprazole treatment, 54 patients (66.7%) responded well with full symptom resolution. Cow's milk was empirically eliminated for 4 weeks from the diets of the remaining 27 patients who did not respond to omeprazole. All signs and symptoms of GERD resolved in all 27 patients following the 4-week elimination of cow's milk.
Farahmand F, Najafi M, Ataee P, et al. Gut Liver, 2011. PMID 21927657
2011 / Multicenter, randomized, double-blind, cross-over placebo-controlled trial
In a randomized, double-blind, cross-over study, patients with irritable bowel syndrome were assigned to take 60 mL of Aloe vera or placebo orally twice daily, separated by a washout period. A total of 110 patients were randomized, with 47 completing all questionnaires and both treatment periods. Statistical analysis demonstrated no difference in quality of life outcomes between Aloe vera and placebo. Authors noted that dropouts and other confounding factors may have affected the study's power to detect a clinically meaningful difference.
Hutchings HA, Wareham K, Baxter JN, et al. ISRN Gastroenterol, 2011. PMID 21991499
2011 / Repeated-measure, crossover dietary intervention
A repeated-measure, crossover dietary intervention in human volunteers investigated the effects of consuming a wild blueberry drink versus a placebo drink for six weeks on the intestinal microbiota. Bifidobacterium spp. significantly increased relative to total eubacteria following blueberry treatment (P ≤ 0.05). Lactobacillus acidophilus increased following both treatments (P ≤ 0.05), while no significant differences were observed for Bacteroides spp., Prevotella spp., Enterococcus spp., or Clostridium coccoides.
Vendrame S, Guglielmetti S, Riso P, et al. J Agric Food Chem, 2011. PMID 22060186
2011 / Randomized trials (two crossover, one parallel)
Three feeding trials assessed gastrointestinal symptoms in adults consuming one-half cup of beans or control daily for 8 to 12 weeks. During the first week, fewer than 50% of participants reported increased flatulence with pinto or baked beans, and only 19% reported increases with black-eyed peas. Across the trials, 3% to 11% of participants also reported heightened flatulence while consuming control diets lacking flatulence-causing ingredients.
Winham DM, Hutchins AM Nutr J, 2011. PMID 22104320
2010 / Randomized double-blind placebo-controlled trial
A randomized double-blind placebo-controlled study assigned 90 outpatients with irritable bowel syndrome to take enteric-coated peppermint oil capsules or placebo three times daily for 8 weeks. By week 8, 14 participants in the peppermint oil group were free from abdominal pain or discomfort compared with 6 in the control group (P < 0.001). Peppermint oil also significantly reduced abdominal pain severity and improved quality of life, without causing significant adverse reactions.
Merat S, Khalili S, Mostajabi P, et al. Dig Dis Sci, 2010. PMID 19507027
2010 / Randomized controlled trial
Hyperinsulinaemic adults were randomized to consume either a high-wheat fibre cereal (24 g fibre/d; 14 completed) or a low-fibre control cereal (14 completed) daily for 1 year. There were no differences in body weight between groups. After 9 months, baseline-adjusted mean 8 h acetate and butyrate levels were significantly higher on the high-fibre cereal than control (P < 0.05). After 12 months, baseline-adjusted mean plasma GLP-1 in the high-fibre group was 1.3 pmol/l (95% CI 0.4, 2.2; P < 0.05) higher than baseline (~25% increase) and 1.4 pmol/l (95% CI 0.1, 2.7; P < 0.05) higher than the control group.
Freeland KR, Wilson C, Wolever TM Br J Nutr, 2010. PMID 19664300
2010 / Randomized crossover pilot trial
Six hyperinsulinaemic female subjects were given 20 mmol sodium acetate intravenously, 60 mmol acetate rectally, or normal saline rectally or intravenously across four separate occasions in randomized order. Change in plasma PYY was significantly higher after acetate (9.69 pg/ml) versus saline (0.60 pg/ml) and after rectal (13.78 pg/ml) versus intravenous infusions (-3.1 pg/ml; P < 0.01). Change in plasma GLP-1 was increased by rectal and acetate infusions (0.25 and 0.23 mmol/l) versus intravenous and saline (-0.26 and -0.19 mmol/l; P < 0.01). Acetate decreased TNF-alpha compared with saline (-0.8 vs 0.15 pg/ml; P < 0.05), while rectal infusions increased TNF-alpha and ghrelin versus intravenous infusions (P < 0.01); no effect was observed for adiponectin.
Freeland KR, Wolever TM Br J Nutr, 2010. PMID 19818198
2010 / Randomized crossover trial
Seventeen healthy adult male volunteers consumed a 300 ml ice cream test meal (675 kcal) in random order across two sessions, taking either 5 minutes or 30 minutes. Peptide YY (PYY) area under the curve (AUC) was significantly higher after the 30-min meal compared to the 5-min meal (5250 +/- 330 vs. 4133 +/- 324 pmol/liter . min, P = 0.004), as was glucagon-like peptide-1 (GLP-1) AUC (8794 +/- 656 vs. 6219 +/- 256 pmol/liter . min, P = 0.001). There was a trend toward higher fullness ratings immediately after the 30-min meal, with no differences observed in ghrelin response.
Kokkinos A, le Roux CW, Alexiadou K, et al. J Clin Endocrinol Metab, 2010. PMID 19875483
2010 / Randomized, single-blind, crossover trial
In a randomized, single-blind crossover trial, 12 healthy subjects consumed 400 mL drinks containing 80 g HFCS, 56 g HFCS, or 56 g HFCS plus 24 g inulin, with a standard lunch served at 4 hours. Glucose and insulin responses did not differ significantly between treatments. Serum acetate, propionate, and butyrate were significantly higher from 4 to 6 hours after inulin compared to the HFCS drinks. Free fatty acids were significantly lower after inulin compared to 56HFCS at 4 hours (0.40 +/- 0.06 vs. 0.51 +/- 0.06 mmol*L-1; p < 0.05). Compared with 56HFCS, inulin also significantly increased glucagon-like peptide-1 at 30 minutes and reduced ghrelin at 4.5 and 6 hours.
Tarini J, Wolever TM Appl Physiol Nutr Metab, 2010. PMID 20130660